A Foxo/Notch pathway controls myogenic differentiation and fiber type specification

Journal of Clinical Investigation

Volumn 117, Issue 9, 2007, Pages 2477-2485

  Kitamura, Tadahiro ^a,b   Kitamura, Yukari Ido ^a   Funahashi, Yasuhiro ^a   Shawber, Carrie J ^a   Castrillon, Diego H ^c   Kollipara, Ramya ^d   DePinho, Ronald A ^d   Kitajewski, Jan ^a   Accili, Domenico ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b GUNMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR FOXO;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SKELETAL MUSCLE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MUSCLE, SKELETAL; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 34848838902     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32054     Document Type: Article

References (53)

1. Singec, I., Jandial, R., Crain, A., Nikkhah, G., and Snyder, E.Y. 2007. The leading edge of stem cell therapeutics. Annu. Rev. Med. 58:313-328.
2. Accili, D., and Arden, K.C. 2004. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 117:421-426.
3. Hribal, M.L., Nakae, J., Kitamura, T., Shutter, J.R., and Accili, D. 2003. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J. Cell Biol. 162:535-541.
4. Nakae, J., et al. 2003. The forkhead transcription factor foxo1 regulates adipocyte differentiation. Dev. Cell. 4:119-129.
5. Potente, M., et al. 2005. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115:2382-2392. doi:10.1172/JCI23126.
6. Liu, Z.P., Wang, Z., Yanagisawa, H., and Olson, E.N. 2005. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell. 9:261-270.
7. Castrillon, D.H., Miao, L., Kollipara, R., Horner, J.W., and DePinho, R.A. 2003. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 301:215-218.
8. Tothova, Z., et al. 2007. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 128:325-339.
9. Paik, J.H., et al. 2007. Foxos are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 128:309-323.
10. Shawber, C.J., and Kitajewski, J. 2004. Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays. 26:225-234.
11. Lai, E.C. 2002. Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins. EMBO Rep. 3:840-845.
12. Jensen, J., et al. 2000. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24:36-44.
13. Ross, D.A., Rao, P.K., and Kadesch, T. 2004. Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes. Mol. Cell. Biol. 24:3505-3513.
14. Ohtsuka, T., et al. 1999. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J. 18:2196-2207.
15. Shawber, C., et al. 1996. Notch signaling inhibits muscle cell differentiation through a CBF1-independent pathway. Development. 122:3765-3773.
16. Sasai, Y., Kageyama, R., Tagawa, Y., Shigemoto, R., and Nakanishi, S. 1992. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev. 6:2620-2634.
17. Kuroda, K., et al. 1999. Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis. J. Biol. Chem. 274:7238-7244.
18. Nofziger, D., Miyamoto, A., Lyons, K.M., and Weinmaster, G. 1999. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development. 126:1689-1702.
19. Wilson-Rawls, J., Molkentin, J.D., Black, B.L., and Olson, E.N. 1999. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol. Cell. Biol. 19:2853-2862.
20. Hirsinger, E., et al. 2001. Notch signalling acts in postmitotic avian myogenic cells to control MyoD activation. Development. 128:107-116.
21. Conboy, I.M., and Rando, T.A. 2002. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell. 3:397-409.
22. Shawber, C.J., Das, I., Francisco, E., and Kitajewski, J. 2003. Notch signaling in primary endothelial cells. Ann. N. Y. Acad. Sci. 995:162-170.
23. Limbourg, F.P., et al. 2005. Essential role of endothelial Notch1 in angiogenesis. Circulation. 111:1826-1832.
24. Hosaka, T., et al. 2004. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U. S. A. 101:2975-2980.
25. Krebs, L.T., et al. 2000. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14:1343-1352.
26. McKinsey, T.A., Zhang, C.L., and Olson, E.N. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11:497-504.
27. Rudnicki, M.A., and Jaenisch, R. 1995. The MyoD family of transcription factors and skeletal myogenesis. Bioessays. 17:203-209.
28. Bassel-Duby, R., and Olson, E.N. 2006. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75:19-37.
29. Schiaffino, S., and Reggiani, C. 1996. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 76:371-423.
30. Lin, J., et al. 2002. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 418:797-801.
31. Lagouge, M., et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127:1109-1122.
32. Nickoloff, B.J., Osborne, B.A., and Miele, L. 2003. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 22:6598-6608.
33. Nickoloff, B.J., et al. 2002. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ. 9:842-855.
34. Pan, Y., et al. 2004. gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev. Cell. 7:731-743.
35. Dowell, P., Otto, T.C., Adi, S., and Lane, M.D. 2003. Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. J. Biol. Chem. 278:45485-45491.
36. Nakae, J., Kitamura, T., Silver, D.L., and Accili, D. 2001. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108:1359-1367. doi:10.1172/JCI200112876.
37. Kovall, R.A., and Hendrickson, W.A. 2004. Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA. EMBO J. 23:3441-3451.
38. Hsieh, J.J., and Hayward, S.D. 1995. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. Science. 268:560-563.
39. Kao, H.Y., et al. 1998. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 12:2269-2277.
40. Tun, T., et al. 1994. Recognition sequence of a highly conserved DNA binding protein RBP-J kappa. Nucleic Acids Res. 22:965-971.
41. Kawaichi, M., et al. 1992. Genomic organization of mouse J kappa recombination signal binding protein (RBP-J kappa) gene. J. Biol. Chem. 267:4016-4022.
42. Fryer, C.J., White, J.B., and Jones, K.A. 2004. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell. 16:509-520.
43. Liang, Y., Chang, J., Lynch, S.J., Lukac, D.M., and Ganem, D. 2002. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16:1977-1989.
44. Hughes, S.M., et al. 1993. Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development. 118:1137-1147.
45. Kitamura, T., et al. 2002. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J. Clin. Invest. 110:1839-1847. doi:10.1172/JCI200216857.
46. Daitoku, H., Yamagata, K., Matsuzaki, H., Hatta, M., and Fukamizu, A. 2003. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes. 52:642-649.
47. Miele, L., Miao, H., and Nickoloff, B.J. 2006. NOTCH signaling as a novel cancer therapeutic target. Curr. Cancer Drug Targets. 6:313-323.
48. Accili, D. 2004. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes. 53:1633-1642.
49. Knapp, J.R., et al. 2006. Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size. Development. 133:601-610.
50. Ogilvie, R.W., and Feeback, D.L. 1990. A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIA, IIB and IIC. Stain Technol. 65:231-241.
51. Das, I., et al. 2004. Notch oncoproteins depend on gamma-secretase/ presenilin activity for processing and function. J. Biol. Chem. 279:30771-30780.
52. Chi, T., Yan, Z., Xue, Y., and Wang, W. 2004. Purification and functional analysis of the mammalian SWI/SNF-family of chromatin-remodeling complexes. Methods Enzymol. 377:299-316.
53. Puigserver, P., et al. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 423:550-555.